Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCCR in Hypertriglyceridemia
NCT01211847Phase 2Completed
- Sponsor
- Essentialis, Inc.
- Start
- Oct 2010
- Primary completion
- Sep 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of diazoxide in hypertriglyceridemia, sponsored by Essentialis, Inc.. Started Oct 2010; status: completed.
02
Drugs
diazoxide
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01211847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01211847.